Publication | Closed Access

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

ThrombosisIschemic StrokeCardiovascular DiseaseMedicineStroke TreatmentCerebrovascular DiseaseRehabilitationNeurologyEcass IiiCerebrovascular InterventionCerebral Blood FlowPublic HealthStrokeNeurological AssessmentIschemic SyndromeAcute Ischaemic Stroke